Pharma / Biotech

CDK 4/6 Regimen Shines in Younger BC Women

Cyclin-dependent kinase (CDK) 4/6 inhibitors have been shown to double progression-free survival (PFS) in postmenopausal women when added to endocrine therapy.

Source link

Related posts

DAY-TIME NON-DROWSY COLD/FLU RELIEF (Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hcl) Liquid [Discount Drug Mart]

Newsemia

ZOLPIDEM TARTRATE Tablet, Film Coated, Extended Release [Preferred Pharmaceuticals Inc.]

Newsemia

journal pharmacology; +768 new citations

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World